<DOC>
	<DOCNO>NCT00542646</DOCNO>
	<brief_summary>The occurrence Peripheral Vascular Disease increase include large artery upper leg call Superficial Femoral Artery ( SFA ) . The Peritoneal Lined Stent develop new method treating narrow area SFA . This research study determine safety effectiveness Peritoneal Lined Stent keep th Superficial Femoral Artery open allow blood flow leg .</brief_summary>
	<brief_title>Pilot Study Evaluate Safety Preliminary Efficacy Peritec Peritoneal Lined Stent Delivery System</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Patient claudication ischemic rest pain ( Rutherford Categories 24 ) The angiogram need perform confirm superficial femoral artery short segment occlusion ( &lt; 5cm first two patient &lt; 10cm ) high grade ( &gt; 50 % ) stenosis Patient sign date informed consent Patient rest ABI &lt; 0.9 abnormal exercise ABI rest ABI normal . Patients incompressible artery ( ABI &gt; 1.2 ) must TBI &lt; 0.8 Life expectancy great one year The ability comply protocol follow requirement require test Angiographic lesion requirement assess time procedure Lesion superficial femoral artery short segment occlusion ( &lt; 5cm first two patient &lt; 10cm ) high grade ( &gt; 50 % ) stenosis Target lesion 1 cm profunda/superficial femoral artery origin 3cm knee joint Angiographic evidence minimum least one tibial continuous artery runoff ankle require intervention Guidewire successfully traverse lesion within true lumen distal vessel , successful placement 9 french ( Fr ) sheath Untreated iliac artery inflow limit lesion Significant proximal common femoral superficial femoral artery disease target lesion Any previously treat superficial femoral artery lesion Any previous stenting surgery target vessel Femoral popliteal aneurysm NonAtherosclerotic disease result occlusion ( e.g . embolism , vasculitis , etc ) Serum creatinine &gt; 2.5 mg/dl Any previously know coagulation disorder , include hypercoagulability Severe medical comorbidities medical condition ( example untreated coronary heart disease congestive heart failure , severe chronic obstructive pulmonary disease , metastasis malignance , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>